CIMBALA@BIONET-20.ARPA (05/03/88)
From: Jim.Cassatt@BIONET-20.ARPA (czj%nihcu.bitnet)
---------------
Return-Path: <@CUNYVM.CUNY.EDU:CZJ@NIHCU.BITNET>
Received: from CUNYVM.CUNY.EDU by BIONET-20.ARPA with TCP; Mon 2 May 88 18:06:32-PDT
Received: from NIHCU.BITNET by CUNYVM.CUNY.EDU (IBM VM SMTP R1.1) with BSMTP id 5944; Mon, 02 May 88 21:08:05 EDT
To: science-resources@bionet-20.arpa
From: CZJ%NIHCU.BITNET@CUNYVM.CUNY.EDU
Date: Mon, 02 May 88 20:48:20 EDT
Subject: NIH Guide 4/29/88
From the NIH Guide to Grants and Contracts - 4/29/88. Included are
the Table of Contents and items of interest.
Jim Cassatt
-------------------------------------------------------------------
Vol. 17, No. 16, April 29, 1988
DATED ANNOUNCEMENTS (RFPs AND RFAs)
RESOURCE FOR COLLECTION AND EVALUATION OF HUMAN TISSUES AND
CELLS FROM DONORS WITH EPIDEMIOLOGICAL PROFILES (RFP)....(84/128)........... 1
National Cancer Institute
Index: CANCER
DENTIST SCIENTIST AWARD - INSTITUTIONAL (K16) (RFA)....(131/184, 564/1033).. 1
National Institute of Dental Research
Index: DENTAL RESEARCH
DEVELOPMENT AND CHANGE IN PLANNING SKILLS THROUGHOUT
THE LIFE SPAN (RFA)...................................(187/311, 1036/1415).. 2
National Institute of Child Health and Human Development
National Institute on Aging
Index: CHILD HEALTH AND HUMAN DEVELOPMENT; AGING
IRON OVERLOAD: COOLEY'S ANEMIA AND OTHER DISORDERS (RFA).....(321/353)..... 4
National Heart, Lung, and Blood Institute (1418/1797)
Index: HEART, LUNG, AND BLOOD
NCI COMPREHENSIVE MINORITY BIOMEDICAL PROGRAM CANCER CENTERS MINORITY
ENHANCEMENT AWARDS (RFA)...........................(356/438, 1800/2133)..... 4
National Cancer Institute
Index: CANCER
IMPROVEMENT OF HOLDING FACILITIES FOR HIV-INFECTED CHIMPANZEES (RFA)........ 5
Division of Research Resources (441/511, 2136/2553)
Index: RESEARCH RESOURCES
RESOURCE FOR COLLECTION AND EVALUATION OF HUMAN TISSUES AND
CELLS FROM DONORS WITH EPIDEMIOLOGICAL PROFILES
RFP AVAILABLE: NCI-CP-85646-13
P.T. 34; K.W. 0780015, 0780020, 0785055, 0715035
National Cancer Institute
The Laboratory of Human Carcinogenesis of the Division of Cancer Etiology,
National Cancer Institute, National Institutes of Health, is recompeting a
tissue-collection contract which is currently being performed by the
University of Maryland. Proposals are now being solicited from qualified
firms to provide the necessary resources for the collection of viable
surgical, biopsy, and autopsy specimens from a variety of human tissues and
cells (lung, bronchus, colon, liver, pancreas) and other biological specimens
(pleural effusions, blood and urine) from donors with epidemiological profiles
prepared in specifically designed patient questionnaires which include the
relevant medical records. The Laboratory of Human Carcinogenesis subjects
these tissues and cells to in vitro adaptability, carcinogenesis, and
biochemical characterizations for chemical and oncogene-induced micromolecular
alterations. These studies facilitate development of innovative methods for
biochemical and epidemiological study of populations at risk for chemical
carcinogenesis. Relevant studies are expanded by xenotransplantation
techniques for definitive assay of chemically stimulated tumorigenesis.
It is planned that RFP No. NCI-CP-85646-13 will be available on or about May
13, 1988. Proposals will be due approximately 45 days following the actual
date of RFP issuance. The National Cancer Institute will consider proposals
from all reponsible sources. However, offerors must demonstrate in their
technical proposal their ability to facilitate delivery of the nonfrozen
viable tissues to the National Cancer Institute in Bethesda, Maryland, within
two hours of collection as a mandatory requirement of the RFP. Failure to
demonstrate this element will result in the offeror's elimination from further
consideration. It is anticipated that approximately 13,840 staff hours will
be required annually for this four-year contract.
Copies of the RFP may be obtained by sending a written request to:
Sharon A. Miller, Contract Specialist
National Cancer Institute, RCB
Blair Building, Room 114
National Institutes of Health
Bethesda, Maryland 20892
Telephone: (301) 427-8888
IRON OVERLOAD: COOLEY'S ANEMIA AND OTHER DISORDERS
RFA AVAILABLE: NIH-88-HL-14-B
P.T. 34; K.W. 0785070, 0750010
National Heart, Lung, and Blood Institute
Application Receipt Date: September 19, 1988
The Blood Diseases Branch of the Division of Blood Diseases and Resources,
National Heart, Lung, and Blood Institute, announces the availability of a
Request for Applications (RFA) on the above subject. Copies of the RFA are
currently available from staff of the Blood Diseases Branch.
The purpose of this initiative is to stimulate clinical and basic research on
the development or evaluation of new or improved therapies for the management
of iron overload in Cooley's anemia or other transfusion-related iron loading
disorders. This special RFA program is intended to be for FIVE years of
support. It is anticipated that about six grants will be awarded under this
program. The specific amount to be funded will, however, depend on the merit
and scope of the applications received and the availability of funds.
Requests for copies of the complete RFA should be addressed to:
Alan S. Levine, Ph.D.
Chief, Blood Diseases Branch
Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute
Federal Building, Room 5A12
National Institutes of Health
Bethesda, Maryland 20892
Telephone: (301) 496-5911
NCI COMPREHENSIVE MINORITY BIOMEDICAL PROGRAM CANCER CENTERS MINORITY
ENHANCEMENT AWARDS
RFA AVAILABLE: 88-CA-11
P.T. 04, FF; K.W. 0715035, 0710030, 0745020, 0745055, 0415000, 0710095
National Cancer Institute
Letter of Intent Date: June 1, 1988
Application Receipt Date: August 2, 1988
INTRODUCTION
1. Background
The Division of Cancer Prevention and Control (DCPC) and the Division of
Extramural Activities (DEA), National Cancer Institute, invite applications
for supplemental support to Cancer Center grants to expand minority
involvement in cancer control research. Cancer Centers would promote the
participation of minority groups in cancer control research by broadening
their operational base to facilitate the expansion of cancer control research
efforts in early detection, prevention, screening, pre-treatment evaluation,
treatment, continua-tion care rehabilitation; and the increased involvement of
minority population primary care providers early in the course of clinical
treatment. The program effort would also promote the participation of
minorities in treatment clinical research that utilizes institutional
protocols. The effort would seek to support programs carrying out cancer
control research activities related to diet and nutrition and would hopefully
coordinate the contributions of investigators from various relevant
disciplines, e.g., behavioral psychology and nutrition science.
The present RFA announcement is for a single competition with a deadline of
August 2, 1988. Applications should be prepared and submitted in accordance
with the aims and requirements described in the complete RFA document and
summarized in the following sections.
II. Research Goals and Scope
This program effort would promote the participation of minorities in cancer
control activities at those cancer centers with funded Cancer Center Support
Grants which access large or predominately minority populations.
4
A supplement to a Cancer Center Support Grant (P30 "core grant") would provide
monies for increased minority involvement in a variety of activities by the
centers including the enrollment of increased numbers of minority patients on
cancer treatment and cancer control potocols.
III. Mechanism of Support
Support will be provided through a competitively awarded core grant supplement
at a maximum projected annual direct cost of $150,000. Funds may be requested
to support: data management, supplies, salaries of professional and/or
support personnel, computer time, administrative expenses, etc., in accordance
with PHS grant policies for Cancer Center Support Grants. The request must be
justified in the budget section of the application.
The initial review of applications will be conducted by the Division of
Extramural Activities, NCI, using a Special Review Committee. Final review is
provided by the National Cancer Advisory Board. It is anticipated that five
awards will be made subject to receipt of meritorious applications and
continued availability of funds.
IV. Inquiries
A copy of the complete RFA describing the research goals and scope, the review
criteria, and the method of applying can be obtained by contacting:
Dr. Lemuel A. Evans
Program Director, Comprehensive Minority
Biomedical Program
Division of Extramural Activities
National Cancer Institute
Building 31, Room 10A-04
Bethesda, Maryland 20892
Telephone: (30l) 496-7344
Inquiries concerning this announcement are encouraged and should be directed
to Dr. Lemuel A. Evans at the above address and phone number. The program
staff would appreciate the opportunity to clarify any issues or questions.
-------